These results suggest that cybernin-3-O-glucoside alleviates NAFLD by activating PTEN-induced kinase 1 (PINK1)-mediated mitochondrial phagocytosis. This evidence concerns the gene PINK1 and metabolic dysfunction-associated steatotic liver disease.